Clinical trial
Comparison of Regadenoson (Rapiscan) and Central Intravenous Adenosine for Measurement of Fractional Flow Reserve
NCT01809743 is registered in ClinicalTrials.gov with Lokien van Nunen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Regadenoson (Rapiscan) and Central Intravenous Adenosine for Measurement of Fractional Flow Reserve
- Lead sponsor
- Lokien van Nunen
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- October 31, 2013
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.